Edgewise Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Edgewise Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Edgewise Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Edgewise Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 69k | 16.22 |
| 2025-03-31 | $2.0M | 91k | 22.00 |
| 2024-12-31 | $3.3M | 124k | 26.70 |
| 2024-09-30 | $4.2M | 159k | 26.69 |
| 2024-06-30 | $1.2M | 64k | 18.01 |
| 2024-03-31 | $781k | 43k | 18.24 |
| 2023-12-31 | $438k | 40k | 10.94 |
| 2023-09-30 | $232k | 41k | 5.73 |
| 2023-06-30 | $276k | 36k | 7.75 |
| 2023-03-31 | $16k | 2.3k | 6.83 |
| 2022-12-31 | $212k | 24k | 8.74 |
| 2022-06-30 | $169k | 21k | 7.99 |
| 2022-03-31 | $261k | 27k | 9.62 |
| 2021-12-31 | $338k | 22k | 15.35 |